KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Curent Deferred Tax Liability Current Assets Current Deferred Tax Assets Current Taxes Dividends payables Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Notes Payables Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Eli Lilly (LLY) Operating Leases (2019)

Eli Lilly's Operating Leases history spans 1 years, with the latest figure at $486.7 million for Q4 2019.

For Q4 2019, Operating Leases changed N/A year-over-year to $486.7 million; the TTM value through Dec 2019 reached $486.7 million, changed N/A, while the annual FY2019 figure was $486.7 million, N/A changed from the prior year.
Operating Leases reached $486.7 million in Q4 2019 per LLY's latest filing, down from $611.5 million in the prior quarter.
In the past five years, Operating Leases ranged from a high of $621.9 million in Q1 2019 to a low of $486.7 million in Q4 2019.